ExeVir Bio

Foundation date

10/07/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

ExeVir Bio is a clinical stage company harnessing its VHH technology platform to generate robust antiviral therapies providing broad protection against viral infections, including pan-coronaviruses. It is a spin out from VIB, the world class Belgium-based life sciences research institute. ExeVir’s platform is based on the work of and collaboration with Professor Dr. Xavier Saelens and Professor Dr. Nico Callewaert from VIB.

Upcoming events

Latest news

  • Mithra reaches milestone in estetrol skin study

    Tuesday April 9th 2024

  • Stool transplant shows promise for Parkinson's disease

    Thursday April 4th 2024

  • Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

    Wednesday April 3rd 2024

Jobs by ExeVir Bio